Biotechnological applications of recombinant single-domain antibody fragments
2011
Biotechnological Applications of Recombinant Single-Domain Antibody Fragments
publication
Evidence: high
Author Information
Author(s): de Marco Ario
Primary Institution: University of Nova Gorica (UNG)
Conclusion
This work provides a detailed analysis of the applications and efficacy of single-domain antibodies in various biotechnological fields.
Supporting Evidence
- Single-domain antibodies can penetrate solid tumors and cross the blood-brain barrier.
- VHHs have shown effectiveness in controlling bacterial infections and neutralizing toxins.
- These antibodies can be used in various applications, including diagnostics and therapeutics.
Takeaway
Single-domain antibodies are tiny and super strong, making them great for many science and medicine uses, like fighting infections and helping with tests.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website